zum Inhalt springen

Fachbereich Veterinärmedizin


Service-Navigation

    Publikationsdatenbank

    China antimicrobial resistance surveillance network for pets (CARPet), 2018 to 2021 (2023)

    Art
    Zeitschriftenartikel / wissenschaftlicher Beitrag
    Autoren
    Ma, Shizhen
    Chen, Siyu
    Lyu, Yanli
    Huang, Wei
    Liu, Yang
    Dang, Xukun
    An, Qi
    Song, Yu
    Jiao, Ying
    Gong, Xiaowei
    Wang, Qian
    Shi, Yuqian
    Li, Yifei
    Shao, Dongyan
    Zou, Zhiyu
    Zhang, Kaiying
    Li, Luxin
    Zhang, Gege
    Yang, Tengkun
    Yang, Lu
    Zhang, Zhenbiao
    Zhang, Haixia
    Chen, Yanyun
    Li, Gebin
    Wang, Yongqiang
    Wang, Lu
    Shen, Zhangqi
    Wu, Congming
    Hu, Fupin
    Schwarz, Stefan (WE 7)
    Wang, Yang
    Xia, Zhaofei
    Shen, Jianzhong
    Quelle
    One health advances
    Bandzählung: 1
    Heftzählung: 7
    Seiten: 1 – 13
    ISSN: 2731-9970
    Sprache
    Englisch
    Verweise
    URL (Volltext): https://onehealthadv.biomedcentral.com/articles/10.1186/s44280-023-00008-w
    DOI: 10.1186/s44280-023-00008-w
    Kontakt
    Institut für Mikrobiologie und Tierseuchen

    Robert-von-Ostertag-Str. 7-13
    14163 Berlin
    +49 30 838 51843 / 66949
    mikrobiologie@vetmed.fu-berlin.de

    Abstract / Zusammenfassung

    China Antimicrobial Resistance Surveillance Network for Pets (CARPet) was established in 2021 to monitor the resistance profiles of clinical bacterial pathogens from companion animals. From 2018 to 2021, we recovered and tested 4,541 isolates from dogs and cats across 25 Chinese provinces, with Escherichia coli (18.5%) and Staphylococcus pseudintermedius (17.8%) being the most predominant bacterial species. The Enterobacterales were highly susceptible to tigecycline, meropenem, colistin, and amikacin (70.3%–100.0%), but showed moderate resistance to ampicillin, ceftriaxone, doxycycline, florfenicol, levofloxacin, enrofloxacin, and trimethoprim-sulfamethoxazole (29.3%–56.7%). About 66.3% of Acinetobacter spp. were resistant to florfenicol, with relatively low resistance to another 11 antibiotics (1.2%–23.3%). The Pseudomonas spp. showed high susceptibility to colistin (91.7%) and meropenem (88.3%). The coagulase-positive Staphylococcus spp. showed higher resistance rates to most antimicrobial agents than coagulasenegative Staphylococcus isolates. However, over 90.0% of Staphylococcus spp. were susceptible to linezolid, daptomycin and rifampin, and no vancomycin-resistant isolates were detected. E. faecium isolates demonstrated higher resistance rates to most antimicrobial agents than E. faecalis isolates. Streptococcus spp. isolates showed low resistance to most antimicrobial agents except for doxycycline (78.2%) and azithromycin (68.8%). Overall, the tested clinical isolates showed high rates of resistance to commonly used antimicrobial agents in companion animals. Therefore, it is crucial to strengthen the monitoring of bacterial resistance in pets. By timely and effectively collecting, analyzing, and reporting antimicrobial resistance dynamics in pets, the CARPet network will become a powerful platform to provide scientific guidance for both pet medical care and public health.